Chemours vs Innospec
CC and IOSP side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CC and IOSP compare
Chemours and Innospec are about the same size, with market caps of $2.0B and $1.9B.
Innospec grew revenue faster over the last twelve months (4.7% versus 0.07% for Chemours).
Both pay dividends: Chemours yields 2.6% and Innospec 2.3%.
Innospec scores higher on the StockData Score (14 against 5 for Chemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CC | IOSP |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $1.9B |
| Share price | $13.35 | $79.11 |
| Change, 1 year | 5.5% | 4.6% |
| Change, 5 years | −58.0% | −9.4% |
| Beta (5Y) | 1.56 | 0.86 |
| Employees | 5,700 | 2,450 |
| StockData Score | ||
| Total score | 5 | 14 (better) |
| Valuation score | 1 | 4 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 1 | 1 |
| Health score | 1 | 6 (better) |
| Dividend score | 2 | 2 |
| Valuation | ||
| P/S | 0.3× (better) | 1.0× |
| P/B | 13.0× | 1.4× (better) |
| EV/EBITDA | 7.1× (better) | 8.4× |
| P/FCF | 9.5× | – |
| FCF yield | 10.5% | – |
| Fair value | – | $109.79 |
| Margin of safety | – | 27.9% |
| Growth | ||
| Revenue growth (TTM) | 0.07% | 4.7% (better) |
| Revenue growth, 5Y average | 3.2% | 8.3% (better) |
| EPS growth, 5Y average | – | 32.1% |
| Profitability | ||
| Gross margin | 15.2% | 27.7% (better) |
| Operating margin | – | 8.8% |
| Net margin | −2.6% | – |
| FCF margin | 3.6% | – |
| Return on equity | −71.8% | – |
| Return on invested capital | – | 12.4% |
| Financial health | ||
| Debt / equity | 24.73 (better) | 0.00 |
| Net debt / EBITDA | 4.32 | – |
| Current ratio | 1.81 | 2.95 (better) |
| Altman Z-score | 1.41 | 5.08 (better) |
| Piotroski F-score | 4 | – |
| Dividends and buybacks | ||
| Dividend yield | 2.6% (better) | 2.3% |
| Years of dividend growth | 0 | 12 (better) |
| Dividend growth, 5Y average | −12.5% | 10.5% (better) |
| Buyback yield | – | 0.69% |
| Shareholder yield | 2.6% | 3.0% (better) |
| Ownership | ||
| Held by institutions | 90.2% | 101% |
| Held by insiders | 0.96% | 1.6% |
| Insider net buying, 12 months | $489K (better) | −$902K |
| Short interest, % of float | 9.8% | 1.9% |
Go deeper
- CC stock overview
- CC income statement
- CC valuation and score
- IOSP stock overview
- IOSP income statement
- IOSP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.